Thursday, July 9, 2026

pharma · Renal Insufficiency, Chronic · REVB

REVELATION BIOSCIENCES

REVELATION BIOSCIENCES clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

San Diego, USA HQ
2020 Founded
14 Employees
Public company Type
REVB · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2020
Employees
14
Programs
1
Drugs
1
Patents
2
Intelligence · Clinical Programs

REVELATION BIOSCIENCES projects

1 ClinicalTrials.gov programs sponsored by REVELATION BIOSCIENCES.

REVELATION BIOSCIENCES has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Intravenous Gemini

    REVELATION BIOSCIENCES, INC.

    Renal Insufficiency, Chronic

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does REVELATION BIOSCIENCES have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.